ConductScience.org, home

Trial · NCT07425600

Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass

NCT07425600, Not yet recruiting, Centre Hospitalier Universitaire de Saint Etienne

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass. Trials, record NCT07425600. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07425600

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass
NCT number
NCT07425600
Status
Not yet recruiting
Enrollment
150 participants, estimated
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Conditions
Fibrinogen Deficiency in Complex Cardiac Surgery
Interventions
Blood samples for PK
First posted
2026-02-23
Last updated
2026-04-22

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCharacterize the sources of variability in plasma fibrinogen levels in response to administration of fibrinogen concentrate after cardiac surgery with cardiopulmonary bypass.During surgery (day 0) (before transfusion then at 10min, 1 hour, 3 hours, 6 hours, 9 hours, 12 hours after transfusion) then at day 1, day 2, day 4 and day 6.Measurement of blood samples using the Clauss technique
SecondaryCharacterize the sources of variability in response to fibrinogen concentrate administration as assessed by the ROTEM viscoelastic test.During surgery (day 0) (before transfusion then at 10min, 1 hour, 3 hours, 6 hours, 9 hours, 12 hours after transfusion) then at day 1 and day 2.Measurement of blood samples using the ROTEM viscoelastic test
SecondaryCharacterize the sources of variability in response to fibrinogen concentrate administration as assessed by the Quantra viscoelastic test.During surgery (day 0) (before transfusion then at 10min, 1 hour, 3 hours, 6 hours, 9 hours, 12 hours after transfusion) then at day 1 and day 2.measurement of blood samples using the Quantra viscoelastic test
SecondaryCharacterize the correlation between fibrinogen exposure and postoperative bleeding after fibrinogen administration.During surgery (day 0) then at day 1 and day 2.Blood loss in ml measured via surgical drains
SecondaryStudy the relationship between different estimators of fibrinogen concentration.through study completion, an average of 7 daysCorrelation coefficient between the different estimators of fibrinogen concentration and description using a Bland-Altman plot.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07425600

GET https://conductscience.org/api/trials/v1/NCT07425600/registered